SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-015692
Filing Date
2023-05-04
Accepted
2023-05-04 16:00:51
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crdf-20230331.htm   iXBRL 10-Q 1009330
2 EX-31.1 crdf-033123exhibit311.htm EX-31.1 10815
3 EX-31.2 crdf-033123exhibit312.htm EX-31.2 10785
4 EX-32.1 crdf-033123exhibit321.htm EX-32.1 6219
5 EX-32.2 crdf-033123exhibit322.htm EX-32.2 6189
  Complete submission text file 0001628280-23-015692.txt   4932468

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20230331.xsd EX-101.SCH 29918
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20230331_cal.xml EX-101.CAL 66056
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20230331_def.xml EX-101.DEF 110572
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20230331_lab.xml EX-101.LAB 405511
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20230331_pre.xml EX-101.PRE 242933
48 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20230331_htm.xml XML 929195
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 23888447
SIC: 2836 Biological Products, (No Diagnostic Substances)